Cargando…
Revisiting the guidelines for ending isolation for COVID-19 patients
Since the start of the COVID-19 pandemic, two mainstream guidelines for defining when to end the isolation of SARS-CoV-2-infected individuals have been in use: the one-size-fits-all approach (i.e. patients are isolated for a fixed number of days) and the personalized approach (i.e. based on repeated...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315804/ https://www.ncbi.nlm.nih.gov/pubmed/34311842 http://dx.doi.org/10.7554/eLife.69340 |
_version_ | 1783729777108058112 |
---|---|
author | Jeong, Yong Dam Ejima, Keisuke Kim, Kwang Su Iwanami, Shoya Bento, Ana I Fujita, Yasuhisa Jung, Il Hyo Aihara, Kazuyuki Watashi, Koichi Miyazaki, Taiga Wakita, Takaji Iwami, Shingo Ajelli, Marco |
author_facet | Jeong, Yong Dam Ejima, Keisuke Kim, Kwang Su Iwanami, Shoya Bento, Ana I Fujita, Yasuhisa Jung, Il Hyo Aihara, Kazuyuki Watashi, Koichi Miyazaki, Taiga Wakita, Takaji Iwami, Shingo Ajelli, Marco |
author_sort | Jeong, Yong Dam |
collection | PubMed |
description | Since the start of the COVID-19 pandemic, two mainstream guidelines for defining when to end the isolation of SARS-CoV-2-infected individuals have been in use: the one-size-fits-all approach (i.e. patients are isolated for a fixed number of days) and the personalized approach (i.e. based on repeated testing of isolated patients). We use a mathematical framework to model within-host viral dynamics and test different criteria for ending isolation. By considering a fixed time of 10 days since symptom onset as the criterion for ending isolation, we estimated that the risk of releasing an individual who is still infectious is low (0–6.6%). However, this policy entails lengthy unnecessary isolations (4.8–8.3 days). In contrast, by using a personalized strategy, similar low risks can be reached with shorter prolonged isolations. The obtained findings provide a scientific rationale for policies on ending the isolation of SARS-CoV-2-infected individuals. |
format | Online Article Text |
id | pubmed-8315804 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-83158042021-07-28 Revisiting the guidelines for ending isolation for COVID-19 patients Jeong, Yong Dam Ejima, Keisuke Kim, Kwang Su Iwanami, Shoya Bento, Ana I Fujita, Yasuhisa Jung, Il Hyo Aihara, Kazuyuki Watashi, Koichi Miyazaki, Taiga Wakita, Takaji Iwami, Shingo Ajelli, Marco eLife Microbiology and Infectious Disease Since the start of the COVID-19 pandemic, two mainstream guidelines for defining when to end the isolation of SARS-CoV-2-infected individuals have been in use: the one-size-fits-all approach (i.e. patients are isolated for a fixed number of days) and the personalized approach (i.e. based on repeated testing of isolated patients). We use a mathematical framework to model within-host viral dynamics and test different criteria for ending isolation. By considering a fixed time of 10 days since symptom onset as the criterion for ending isolation, we estimated that the risk of releasing an individual who is still infectious is low (0–6.6%). However, this policy entails lengthy unnecessary isolations (4.8–8.3 days). In contrast, by using a personalized strategy, similar low risks can be reached with shorter prolonged isolations. The obtained findings provide a scientific rationale for policies on ending the isolation of SARS-CoV-2-infected individuals. eLife Sciences Publications, Ltd 2021-07-27 /pmc/articles/PMC8315804/ /pubmed/34311842 http://dx.doi.org/10.7554/eLife.69340 Text en © 2021, Jeong et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Microbiology and Infectious Disease Jeong, Yong Dam Ejima, Keisuke Kim, Kwang Su Iwanami, Shoya Bento, Ana I Fujita, Yasuhisa Jung, Il Hyo Aihara, Kazuyuki Watashi, Koichi Miyazaki, Taiga Wakita, Takaji Iwami, Shingo Ajelli, Marco Revisiting the guidelines for ending isolation for COVID-19 patients |
title | Revisiting the guidelines for ending isolation for COVID-19 patients |
title_full | Revisiting the guidelines for ending isolation for COVID-19 patients |
title_fullStr | Revisiting the guidelines for ending isolation for COVID-19 patients |
title_full_unstemmed | Revisiting the guidelines for ending isolation for COVID-19 patients |
title_short | Revisiting the guidelines for ending isolation for COVID-19 patients |
title_sort | revisiting the guidelines for ending isolation for covid-19 patients |
topic | Microbiology and Infectious Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315804/ https://www.ncbi.nlm.nih.gov/pubmed/34311842 http://dx.doi.org/10.7554/eLife.69340 |
work_keys_str_mv | AT jeongyongdam revisitingtheguidelinesforendingisolationforcovid19patients AT ejimakeisuke revisitingtheguidelinesforendingisolationforcovid19patients AT kimkwangsu revisitingtheguidelinesforendingisolationforcovid19patients AT iwanamishoya revisitingtheguidelinesforendingisolationforcovid19patients AT bentoanai revisitingtheguidelinesforendingisolationforcovid19patients AT fujitayasuhisa revisitingtheguidelinesforendingisolationforcovid19patients AT jungilhyo revisitingtheguidelinesforendingisolationforcovid19patients AT aiharakazuyuki revisitingtheguidelinesforendingisolationforcovid19patients AT watashikoichi revisitingtheguidelinesforendingisolationforcovid19patients AT miyazakitaiga revisitingtheguidelinesforendingisolationforcovid19patients AT wakitatakaji revisitingtheguidelinesforendingisolationforcovid19patients AT iwamishingo revisitingtheguidelinesforendingisolationforcovid19patients AT ajellimarco revisitingtheguidelinesforendingisolationforcovid19patients |